The New Maximizer Playbook: What’s Changed–And What to Do About It

The New Maximizer Playbook: What’s Changed–And What to Do About It

September 14, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
Stephen Hom
Stephen Hom Co-founder & COO
GTN InsightsPBM / Payer-based Leakage
Get GTN Insights by Email
What You and Your Team Need to Know About Pharmacy Copay Misuse
What You and Your Team Need to Know About Pharmacy Copay Misuse

August 25, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
GTN InsightsPharmacy-based Leakage
The RIS Rx Pharmacy Fellowship Returns for 2027–2028
The RIS Rx Pharmacy Fellowship Returns for 2027–2028

August 24, 2026

Lia Basilio
Lia Basilio Talent Acquisition Manager & People Ops Business Partner
Our People
RIS Rx Extends Triple A Platform with Real-Time Monitoring Backed by PharmD-to-PharmD Engagement
RIS Rx Extends Triple A Platform with Real-Time Monitoring Backed by PharmD-to-PharmD Engagement

August 13, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
Press Releases
Inside the RIS Rx Security and Data Privacy Program: 5 Safeguards Every Manufacturer Should Verify
Inside the RIS Rx Security and Data Privacy Program: 5 Safeguards Every Manufacturer Should Verify

August 10, 2026

Matthew Webster
Matthew Webster Chief Information Security Officer
Careen Martin
Careen Martin Chief Compliance & Privacy Officer
Our People
Diann Dalton Potestio On The Hidden Cost of Waiting
Diann Dalton Potestio On The Hidden Cost of Waiting

June 17, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
GTN Insights
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

June 4, 2026

Stephen Hom
Stephen Hom Co-founder & COO
GTN InsightsPharmacy-based Leakage
GTN Leakage Is A Solvable Crisis. Learn Why On Our Podcast.
GTN Leakage Is A Solvable Crisis. Learn Why On Our Podcast.

May 11, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
GTN Insights
Welcoming Tom Doyle to the RIS Rx Family
Welcoming Tom Doyle to the RIS Rx Family

April 23, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeopleOur Story
Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.
Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.

April 13, 2026

Stephen Hom
Stephen Hom Co-founder & COO
AFP-based leakageGTN Insights

Learn why the world‘s top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.